Wahl, D.G., Bounameaux, H., de Moerloose, P., et al. (2000) Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: Do the benefits outweight the risks? A decision analysis. Archives of Internal Medicine, 160(13), 2042-2048.

has been cited by the following article:

• TITLE: Myocardial infarction in antiphospholipid antibody syndrome

  AUTHORS: Davide Lazzarini, Luca Morolli, Jonathan Montomoli, Giorgio Ioli

  KEYWORDS: Antiphospholipid Antibody Syndrome; Myocardial Infarction; Anticardiolipin Antibodies; ?2-Glicoprotein Antibodies

  JOURNAL NAME: Health, Vol.2 No.9, September 29, 2010

  ABSTRACT: A 52-year-old man was admitted to hospital with chest pain after physical activity. Emergency coronary angiography showed multiple throm-boembolic occlusions in the anterior descen-ding coronary artery and in the right coronary artery. Further testing revealed anticardiolipin and ?2-glicoprotein antibodies (the patient had been diagnosed for ulcerative colitis and poly-myalgia rheumatica). Heparin and nitrate were administered intravenously in addition to oral aspirin and metoprolol. Soon after, the patient referred a withdrawal of chest oppression, and his general clinical condition rapidly stabilised. A follow-up examination was performed 9 months later the discharge: he had resumed most of his activities and sieric concentration of lupus anticoagulant antibodies and anticardiolipin an- tibodies, IgM isotype, were decreased.